Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J B Marks

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacology in Drug Development|September 11, 2022
Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White ParticipantsLia Liefaard, Eva Hajduk, Frans van den Berg, et al.
British Journal of Haematology|June 15, 2020
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendationsSelina J Chavda, Rachael Pocock, Simon Cheesman, et al.
Hypertension (Dallas, Tex. : 1979)|April 4, 2018
Resistant Hypertension: Trials and TribulationsMarc J George, Daniel J B Marks, Tamer Rezk, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2023
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitisGeert D'Haens, Laurent Peyrin-Biroulet, Daniel J B Marks, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 2, 2022
A qualitative study to explore the symptoms and impacts of Crohn's disease and to develop the Crohn's Disease DiaryRebecca Williams-Hall, Claire Trennery, Kate Sully, et al.
Plos One|January 26, 2012
Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centreDaniel J B Marks, Marie D Fisk, Chieh Y Koo, et al.
The Journal of Experimental Medicine|August 5, 2009
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseAndrew M Smith, Farooq Z Rahman, Bu'Hussain Hayee, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Journal of Crohn'S & Colitis|March 18, 2020
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative ColitisStephanie M Slevin, Lucy C Garner, Conor Lahiff, et al.
Clinical Pharmacology and Therapeutics|October 28, 2020
Depletion of LAG-3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781Joanne Ellis, Daniel J B Marks, Naren Srinivasan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacology in Drug Development|September 11, 2022
Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White ParticipantsLia Liefaard, Eva Hajduk, Frans van den Berg, et al.
British Journal of Haematology|June 15, 2020
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendationsSelina J Chavda, Rachael Pocock, Simon Cheesman, et al.
Hypertension (Dallas, Tex. : 1979)|April 4, 2018
Resistant Hypertension: Trials and TribulationsMarc J George, Daniel J B Marks, Tamer Rezk, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2023
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitisGeert D'Haens, Laurent Peyrin-Biroulet, Daniel J B Marks, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 2, 2022
A qualitative study to explore the symptoms and impacts of Crohn's disease and to develop the Crohn's Disease DiaryRebecca Williams-Hall, Claire Trennery, Kate Sully, et al.
Plos One|January 26, 2012
Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centreDaniel J B Marks, Marie D Fisk, Chieh Y Koo, et al.
The Journal of Experimental Medicine|August 5, 2009
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseAndrew M Smith, Farooq Z Rahman, Bu'Hussain Hayee, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Journal of Crohn'S & Colitis|March 18, 2020
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative ColitisStephanie M Slevin, Lucy C Garner, Conor Lahiff, et al.
Clinical Pharmacology and Therapeutics|October 28, 2020
Depletion of LAG-3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781Joanne Ellis, Daniel J B Marks, Naren Srinivasan, et al.
Pageof 3